Court Place Advisors, LLC Mannkind Corp Transaction History

Court Place Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 07, 2018	SELL	$1.59 - $2.38 $16,090 - $24,085	-10,120 Closed	0 $0
Q1 2018 May 01, 2018	SELL	$2.28 - $3.8 $6,657 - $11,096	-2,920 Reduced 22.39%	10,120 $23,000
Q3 2017 Nov 06, 2017	BUY	$1.15 - $2.29 $14,995 - $29,861	13,040	13,040 $28,000

229

133M

1.43M

849K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.82B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Court Place Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Court Place Advisors, LLC with notifications on news.